viewCambridge Cognition Holdings PLC

Cambridge Cognition software allows Apple Watch to track brain health

The study showed that wearable tech such as the Apple Watch and Microsoft Band can be used to in conjunction with the group’s software to assess brain health.

Man shaking his head graphic
The technology enables doctors to better understand and manage brain health.

Neuroscience group Cambridge Cognition Holdings PLC (LON:COG) said that results from a new technology feasibility study demonstrated for the first time that wearable consumer devices can be used clinically to measure cognitive performance accurately when programmed with the Cognition Kit software

The study showed that wearable tech such as the Apple Watch and Microsoft Band can be used to in conjunction with the group’s software to assess brain health.

A joint venture between Cambridge Cognition and research agency Ctrl Group, the Cognition Kit software was developed to address the growing need for accurate measurement of the brain during treatment.

The technology enables doctors, scientists and patients to better understand and manage day-to-day brain health by measuring the key biological and psychological factors affecting mental performance accurately in real time said the group.

Mental health conditions are among the leading causes of disability worldwide. The World Health Organization estimates that more than 450mln people are living with mental illnesses, the cost of treatment and care to global economies will double by 2030 to over US$6trln.

The market for wearable mental health monitoring is estimated to be worth around US$2bn.

"This proof of concept study demonstrates for the first time that these consumer devices are enabling the rapid and accurate collection of largescale scientific datasets,” said director of research and development Francesca Cormack.

“This not only allows dramatically more detailed knowledge of moment-by-moment brain function but also opens up new possibilities to develop machine learning algorithms that will enable earlier detection and intervention in brain disorders.” 

Quick facts: Cambridge Cognition Holdings PLC

Price: 26.1 GBX

Market: AIM
Market Cap: £6.31 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Group Eleven Resources finds a new investor in mining giant...

Group Eleven Resources (CVE: ZNG) CEO Bart Jaworski joined Steve Darling from Proactive Vancouver on Skype to discuss the news Glencore (LON: GLEN) has entered a shareholder agreement on Group Eleven’s Zinc Exploration in Ireland. Jaworski telling Proactive how the deal works and what it...

4 hours, 10 minutes ago


Director/PDMR Shareholding

3 weeks, 1 day ago

Director/PDMR Shareholding

3 weeks, 4 days ago

Interim Results

4 weeks, 1 day ago

Trading Update

on 27/8/19

Dr. Nick Kerton

on 14/8/19

2 min read